FMP

FMP

Enter

TTNP - Titan Pharmaceutical...

Financial Summary of Titan Pharmaceuticals, Inc.(TTNP), Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of ch

photo-url-https://financialmodelingprep.com/image-stock/TTNP.png

Titan Pharmaceuticals, Inc.

TTNP

NASDAQ

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.

5 USD

0.3495 (6.99%)

About

ceo

Mr. David Elliot Lazar

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therape...

CIK

0000910267

ISIN

US8883147055

CUSIP

888314606

Address

400 Oyster Point Boulevard

Phone

650 244 4990

Country

US

Employee

4

IPO Date

Jan 18, 1996

Summary

CIK

0000910267

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

888314606

ISIN

US8883147055

Country

US

Price

5

Beta

1.18

Volume Avg.

5.43k

Market Cap

4.57M

Shares

-

52-Week

4.24-14.0

DCF

5.8

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.78

P/B

-

Website

https://www.titanpharm.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest TTNP News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep